HSTCOTCPharmaceutical PreparationsFiscal year ends December 31

HST Global, Inc.

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-K on Nov 3, 2025

$0.70+0.57 (+423.56%)

Close on Oct 19, 2026

Market cap: $28.78M
P/E (TTM): –
Dividend yield: –

Fundamental chart

Pick a measure to chart its full history

$0FY2023

Where these numbers come from

Parsed from the XBRL in HST Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on Apr 9, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HSTC.

Company	Revenue	Growth
HSTC	$0	–
PPCB	–	–
AKTX	–	–
RADX	–	–
SNY	–	–
CLCS	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 4
Auditor: Turner, Stone & Company, LLP
SEC CIK: 797564

Advertisement
300 × 250